Christopher Bell PharmD, BCOP
Mass General Cancer Center
Christopher Bell, PharmD, BCOP, is a clinical oncology pharmacist specializing in leukemia and related malignancies at Massachusetts General Hospital and is a board-certified oncology pharmacist.
Dr. Bell completed his PGY1 pharmacy residency at Oregon Health & Science University and his PGY2 oncology pharmacy residency at Nebraska Medicine. He is originally from Salt Lake City, Utah where he completed both his undergraduate and Doctor of Pharmacy degrees at The University of Utah.
Dr. Bell’s clinical and research interests include the treatment of AML and CML, strategies to optimize patient adherence to oral oncolytics, management of drug interactions and toxicities related to chemotherapy, and medication safety.